ISIS PHARMACEUTICALS $20.98

up +0.34


24/5/2013 04:24 PM  |  NASDAQ : ISIS  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
2/21/2013 BERTHELSEN SPENCER R Director 10,000 $5.17 34.13%
2/19/2013 O'NEIL PATRICK R. SVP, Legal & General Counsel 1,600 $10.29 120.85%
2/19/2013 O'NEIL PATRICK R. SVP, Legal & General Counsel -1,600 $14.80 -54.72%
2/15/2013 O'NEIL PATRICK R. SVP, Legal & General Counsel -250 $14.82 -15.88%
2/15/2013 O'NEIL PATRICK R. SVP, Legal & General Counsel -100 $14.80 -7.02%
2/15/2013 O'NEIL PATRICK R. SVP, Legal & General Counsel 250 $10.29 18.88%
2/15/2013 O'NEIL PATRICK R. SVP, Legal & General Counsel 100 $10.29 7.55%
2/13/2013 O'NEIL PATRICK R. SVP, Legal & General Counsel -139 $14.17 -9.50%
2/13/2013 O'NEIL PATRICK R. SVP, Legal & General Counsel -5,200 $14.17 -78.04%
2/13/2013 O'NEIL PATRICK R. SVP, Legal & General Counsel 5,200 $7.25 355.43%
2/13/2013 O'NEIL PATRICK R. SVP, Legal & General Counsel -900 $14.17 -38.09%
2/13/2013 O'NEIL PATRICK R. SVP, Legal & General Counsel 900 $8.00 61.52%
1/30/2013 O'NEIL PATRICK R. SVP, Legal and General Counsel -2,000 $14.82 -57.75%
1/30/2013 O'NEIL PATRICK R. SVP, Legal and General Counsel 2,000 $10.29 136.71%
1/29/2013 O'NEIL PATRICK R. SVP, Legal and General Counsel -300 $13.40 -17.02%
1/17/2013 O'NEIL PATRICK R. SVP, Legal & General Counsel -242 $14.16 -12.07%
1/16/2013 PARSHALL B LYNNE COO, Secretary -759 $14.00 -20.51%
1/16/2013 HOUGEN ELIZABETH L SVP, Finance & CFO -242 $14.00 -44.65%
1/16/2013 Monia Brett P SVP, Antisense Drug Discovery -95 $14.00 -1.64%
1/16/2013 Monia Brett P SVP, Antisense Drug Discovery -235 $14.00 -4.04%
1/16/2013 CROOKE STANLEY T Chairman, CEO and President -143 $14.00 -45.11%
1/16/2013 CROOKE STANLEY T Chairman, CEO and President -1,317 $14.00 -44.22%
1/16/2013 Geary Richard S SVP, Development -345 $14.00 -7.50%
1/16/2013 BENNETT C FRANK SVP, Antisense Research -309 $14.00 -12.77%
1/4/2013 O'NEIL PATRICK R. SVP, Legal and General Counsel -1,296 $10.76 -46.97%
1/3/2013 Geary Richard S Sr VP, Development -265 $10.84 -6.48%
1/3/2013 Monia Brett P VP, Antisense Drug Discovery -311 $10.84 -5.55%
1/1/2013 Geary Richard S Sr VP, Development 898 $8.87 28.15%
1/1/2013 BENNETT C FRANK SVP, Antisense Research 447 $8.87 35.00%
1/1/2013 Monia Brett P VP, Antisense Drug Discovery 215 $8.87 3.99%
1/1/2013 O'NEIL PATRICK R. SVP, Legal and General Counsel 431 $8.87 18.51%
12/13/2012 Geary Richard S Sr VP, Development 6,000 $5.25 188.09%
12/13/2012 Geary Richard S Sr VP, Development -6,000 $9.63 -65.29%
9/21/2012 CROOKE STANLEY T Chairman, CEO and President -29,462 $14.06 -100.00%
9/20/2012 CROOKE STANLEY T Chairman, CEO and President -9,462 $15.01 -100.00%
9/20/2012 CROOKE STANLEY T Chairman, CEO and President 20,538 $15.01 100.00%
9/19/2012 CROOKE STANLEY T Chairman, CEO and President -30,000 $14.82 -100.00%
9/13/2012 CROOKE STANLEY T Chairman, CEO and President -27,074 $14.55 -100.00%
9/7/2012 PARSHALL B LYNNE COO, Secretary -5,000 $15.12 -100.00%
9/7/2012 PARSHALL B LYNNE COO, Secretary -2,506 $15.12 -55.80%
9/7/2012 PARSHALL B LYNNE COO, Secretary 2,506 $6.84 126.25%
9/6/2012 Monia Brett P VP, Antisense Drug Discovery -12,031 $15.25 -69.08%
9/6/2012 CROOKE STANLEY T Chairman, CEO and President -4,381 $15.04 -100.00%
9/6/2012 CROOKE STANLEY T Chairman, CEO and President -1,925 $15.04 -100.00%
9/6/2012 CROOKE STANLEY T Chairman, CEO and President -8,694 $15.04 -100.00%
9/6/2012 CROOKE STANLEY T Chairman, CEO and President -306 $15.00 -100.00%
9/6/2012 CROOKE STANLEY T Chairman, CEO and President -6,000 $15.00 -100.00%
9/6/2012 CROOKE STANLEY T Chairman, CEO and President -8,694 $15.00 -100.00%
9/6/2012 Monia Brett P VP, Antisense Drug Discovery 12,031 $5.25 223.46%
9/6/2012 PARSHALL B LYNNE COO, Secretary -5,000 $15.04 -100.00%
9/6/2012 PARSHALL B LYNNE COO, Secretary 2,494 $6.84 125.64%
9/6/2012 PARSHALL B LYNNE COO, Secretary -2,494 $15.04 -55.68%
9/6/2012 PARSHALL B LYNNE COO, Secretary 2,506 $5.25 126.25%
9/6/2012 PARSHALL B LYNNE COO, Secretary -2,506 $15.04 -55.80%
9/6/2012 PARSHALL B LYNNE COO, Secretary -5,000 $15.00 -100.00%
9/6/2012 REED JOHN C Director -4,900 $15.18 -100.00%
9/5/2012 PARSHALL B LYNNE COO, Secretary 2,000 $5.25 100.76%
9/5/2012 PARSHALL B LYNNE COO, Secretary -2,000 $15.00 -50.19%
9/5/2012 CROOKE STANLEY T Chairman, CEO and President -15,000 $14.82 -100.00%
9/4/2012 CROOKE STANLEY T Chairman, CEO and President -30,000 $14.11 -100.00%
9/4/2012 REED JOHN C Director -5,100 $15.17 -100.00%
9/4/2012 PARSHALL B LYNNE COO, Secretary -10,000 $15.00 -100.00%
7/9/2012 REED JOHN C Director -10,000 $13.99 -100.00%
7/9/2012 Geary Richard S Sr VP, Development -1,000 $13.45 -23.87%
7/9/2012 Geary Richard S Sr VP, Development 1,000 $5.25 31.35%
7/9/2012 Geary Richard S Sr VP, Development -2,000 $13.49 -38.54%
7/9/2012 Geary Richard S Sr VP, Development -2,686 $13.47 -45.71%
7/9/2012 Geary Richard S Sr VP, Development 2,000 $5.25 62.70%
7/9/2012 Geary Richard S Sr VP, Development 2,686 $5.25 84.20%
7/9/2012 BENNETT C FRANK SVP, Antisense Research -5,000 $13.51 -79.66%
7/9/2012 BENNETT C FRANK SVP, Antisense Research 5,000 $6.81 391.54%
7/9/2012 BENNETT C FRANK SVP, Antisense Research -5,500 $13.51 -81.16%
7/9/2012 BENNETT C FRANK SVP, Antisense Research 5,500 $6.84 430.70%
7/3/2012 Geary Richard S Sr VP, Development -2,434 $12.91 -43.28%
7/3/2012 BENNETT C FRANK SVP, Antisense Research -6,000 $12.91 -82.45%
7/3/2012 BENNETT C FRANK SVP, Antisense Research 6,000 $6.84 469.85%
7/3/2012 Monia Brett P SVP, Antisense Drug Discovery -587 $12.92 -9.83%
7/1/2012 Geary Richard S Sr VP, Development 1,300 $6.13 30.06%
7/1/2012 BENNETT C FRANK SVP, Antisense Research 648 $6.13 103.02%
7/1/2012 Monia Brett P SVP, Antisense Drug Discovery 311 $6.13 5.49%
6/25/2012 BERTHELSEN SPENCER R Director 700 $8.15 2.39%
6/25/2012 BERTHELSEN SPENCER R Director -700 $11.56 -2.33%
6/25/2012 BERTHELSEN SPENCER R Director 3,500 $8.15 11.95%
6/25/2012 BERTHELSEN SPENCER R Director -3,500 $11.58 -10.67%
6/25/2012 BERTHELSEN SPENCER R Director 1,500 $8.15 5.12%
6/25/2012 BERTHELSEN SPENCER R Director -1,500 $11.58 -4.87%
6/25/2012 BERTHELSEN SPENCER R Director 100 $8.15 0.34%
6/25/2012 BERTHELSEN SPENCER R Director -100 $11.59 -0.34%
6/25/2012 BERTHELSEN SPENCER R Director 1,600 $8.15 5.46%
6/25/2012 BERTHELSEN SPENCER R Director 172 $8.15 0.59%
6/25/2012 BERTHELSEN SPENCER R Director -172 $11.62 -0.58%
6/25/2012 BERTHELSEN SPENCER R Director -1,600 $11.60 -5.18%
6/25/2012 BERTHELSEN SPENCER R Director -495 $11.55 -1.66%
6/25/2012 BERTHELSEN SPENCER R Director 495 $8.15 1.69%
6/25/2012 BERTHELSEN SPENCER R Director -300 $11.48 -1.01%
6/25/2012 BERTHELSEN SPENCER R Director 200 $8.15 0.68%
6/25/2012 BERTHELSEN SPENCER R Director 300 $8.15 1.02%
6/25/2012 BERTHELSEN SPENCER R Director -200 $11.49 -0.68%
6/25/2012 BERTHELSEN SPENCER R Director -300 $11.49 -1.01%
6/25/2012 BERTHELSEN SPENCER R Director -200 $11.50 -0.68%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (ISIS), click here.
Marketplace
Trading Center